Login / Signup

Belimumab for the treatment of children with frequently relapsing nephrotic syndrome: the BELNEPH study.

Marina VivarelliManuela ColucciAntonio GargiuloChiara BettiniAnna Lo RussoFrancesco Emma
Published in: Pediatric nephrology (Berlin, Germany) (2021)
Short-term treatment with belimumab in pediatric FRNS was well tolerated. The number of patients was too small to draw conclusions on efficacy. Nonetheless, we did not observe clear improvements. The burden of monthly in-hospital i.v. infusions outweighed potential benefits. Persistence of circulating memory B cells supports their pathogenic role in the disease. A higher resolution version of the Graphical abstract is available as Supplementary information.
Keyphrases